Company / Profit Margin
Boston Scientific Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
14.4%
FY2025
5-year range
5.5% / 43.8%
FY2021-FY2025
Trend
+30.8%
vs FY2024
Sector context
#24 of 156
Health Care
What the data says
Boston Scientific's profit margin of 14.4% is higher than 85% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from 1.1% in FY2017 to 43.8% in FY2021.
Based on SEC 10-K filings.
14.4% in FY2025 with a 5-year CAGR of -2.6%. Top quartile in the Health Care sector.
Improved from 11.2% to 14.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +8.9pp
- 5-Year Change
- -2.6pp
- 10-Year Change
- -
Sector benchmark
Top 15% in Health CareTop 15% of 156This company 14.4% Sector average -252.5%
▼
+105.7% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 30.8% year-over-year.
- Currently 266.9pp above the Health Care sector average.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.4% | +30.8% |
| FY2024 | 11.0% | -1.4% |
| FY2023 | 11.2% | +103.3% |
| FY2022 | 5.5% | -87.4% |
| FY2021 | 43.8% | +157.4% |
| FY2020 | 17.0% | -61.1% |
| FY2019 | 43.8% | +157.4% |
| FY2018 | 17.0% | +1379.1% |
| FY2017 | 1.1% | -69.9% |
| FY2016 | 3.8% | +229.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026